Condition : Rheumatic Arthritis Interventions : Biological: YHB1411-2: Level 2; Biological: YHB1411-2: Level 3; Biological: YHB1411-2: Level 4; Biological: YHB1411-2: Level 5; Biological: Placebo; Bio...

The domains of the HAQ-DI are dressing and grooming, arising, eating, walking, hygiene, reach, grip and common daily activities. The total score ranges from 0 to 3 with lower scores meaning lower disa...

Condition : Rheumatoid Arthritis Interventions : Biological: Certolizumab Pegol + Methotrexate (MTX); Biological: Placebo + Methotrexate (MTX) Sponsors : UCB, Inc.; UCB, Inc. Active, not recruiting -...

Condition : Rheumatoid Arthritis Interventions : Biological: Certolizumab Pegol + Methotrexate (MTX); Biological: Placebo + Methotrexate (MTX) Sponsor : UCB, Inc. Active, not recruiting - verified Feb...

The domains of the HAQ-DI are dressing and grooming, arising, eating, walking, hygiene, reach, grip and common daily activities. The total score ranges from 0 to 3 with lower scores meaning lower disa...

The domains of the HAQ-DI are dressing and grooming, arising, eating, walking, hygiene, reach, grip and common daily activities. The total score ranges from 0 to 3 with lower scores meaning lower disa...

Condition : Rheumatoid Arthritis Interventions : Biological: Certolizumab Pegol + Methotrexate (MTX); Biological: Placebo + Methotrexate (MTX) Sponsor : UCB, Inc. Active, not recruiting - verified Nov...

Condition : Juvenile Idiopathic Arthritis Interventions : Drug: CP-690,550; Drug: CP-690,550; Drug: CP-690,550 Sponsor : Pfizer Recruiting - verified February 2014

Condition : Juvenile Idiopathic Arthritis Interventions : Drug: CP-690,550; Drug: CP-690,550; Drug: CP-690,550 Sponsor : Pfizer Recruiting - verified November 2013

Condition : Juvenile Idiopathic Arthritis Interventions : Drug: CP-690,550; Drug: CP-690,550; Drug: CP-690,550 Sponsors : Pfizer; Pfizer Recruiting - verified September 2013